| Invitae Corp (NVTA) | |||
|---|---|---|---|
| 2.52 0.22 (9.57%) | 08-08 16:00 | ||
| Open: | 2.37 | Pre. Close: | 2.3 |
| High: | 2.73 | Low: | 2.26 |
| Volume: | 14,175,370 | Market Cap: | 578M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 2.733 - 2.744 | 2.744 - 2.754 |
| Low: | 2.236 - 2.247 | 2.247 - 2.258 |
| Close: | 2.501 - 2.519 | 2.519 - 2.537 |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 3.22 One year: 3.89 |
| Support: | Support1: 1.83 Support2: 1.52 |
| Resistance: | Resistance1: 2.76 Resistance2: 3.33 |
| Pivot: | 2.13  |
| Moving Averages: | MA(5): 2.19  MA(20): 2.31 MA(100): 4.21 MA(250): 13.26 |
| MACD: | MACD(12,26): -0.16 Signal(12,26,9): -0.21 |
| %K %D: | %K(14,3): 45.77 %D(3): 29.21 |
| RSI: | RSI(14): 53.38 |
| 52-Week: | High: 32.93 Low: 1.83 Change(%): -90.1 |
| Average Vol(K): | 3-Month: 10190 10-Days: 10092 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ NVTA ] has closed It is unclear right now based on current values. 65.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Diagnostics & Research | |
| Shares Out. (M) | 229.29 |
| Shares Float (M) | 215.39 |
| % Held by Insiders | 1.20 |
| % Held by Institutions | 81.35 |
| Shares Short (K) | 50430 |
| Shares Short Prior Month (K) | 50290 |
| Stock Financials | |
|---|---|
| EPS | -2.056 |
| Book Value (p.s.) | 12.430 |
| Profit Margin | -93.93 |
| Operating Margin | -168.91 |
| Return on Assets (ttm) | -11.7 |
| Return on Equity (ttm) | -17.3 |
| Qtrly Rev. Growth | 19.4 |
| Gross Profit (p.s.) | 0.488 |
| Sales Per Share | 2.096 |
| EBITDA (p.s.) | -3.143 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | -617.84 |
| Levered Free Cash Flow (M) | -357.65 |
| Stock Valuation | |
|---|---|
| PE Ratio | -1.23 |
| PEG Ratio | -0.09 |
| Price to Book value | 0.20 |
| Price to Sales | 1.20 |
| Price to Cash Flow | -0.94 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
